# Blacksmith Medicines, Inc.

Canonical: https://abierto.us/vendors/blacksmith-medicines-inc-zcwkwswhajd6

- UEI: ZCWKWSWHAJD6
- CAGE: 6XVV8
- Location: San Diego, CA
- Awards in window: 1 (14 transactions), $8,248,582 obligated, February 9, 2024 to September 11, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $8,248,582

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $8,248,582

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93022C00060 (definitive contract): $8,248,582, National Institutes of Health Niaid. FG-2101: a First-In-Class LPXC Inhibitor for the Treatment of MDR Gramnegative Urinary Tract Infections.. https://www.usaspending.gov/award/CONT_AWD_75N93022C00060_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/blacksmith-medicines-inc-zcwkwswhajd6.